3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Breast Neoplasms
1388
Neoplasms
1168
Colorectal Neoplasms
626
Lung Neoplasms
562
Prostatic Neoplasms
538
Carcinoma, Non-Small-Cell Lung
444
Carcinoma, Hepatocellular
296
Stomach Neoplasms
272
Pancreatic Neoplasms
270
Colonic Neoplasms
264
Ovarian Neoplasms
231
Head and Neck Neoplasms
228
Rectal Neoplasms
221
Melanoma
216
Multiple Myeloma
204
Uterine Cervical Neoplasms
198
Lymphoma
195
Leukemia
193
Precursor Cell Lymphoblastic Leukemia-Lymphoma
191
Neoplasm Metastasis
178
Carcinoma, Renal Cell
177
Brain Neoplasms
174
Esophageal Neoplasms
173
Leukemia, Myeloid, Acute
158
Urinary Bladder Neoplasms
138
Recurrence
123
Polycystic Ovary Syndrome
122
Liver Neoplasms
119
Hematologic Neoplasms
117
Endometrial Neoplasms
107
Interventions
anlotinib
1
Angiogenesis Inhibitors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Observational
×
Stereotactic Body Radiation Therapy
×
Clear all
NCT04912128
2021-06-03
AnloSBRT
Peking University Third Hospital
Completed
30 enrolled